通过调节自,PKM2调节化疗敏感性,并预测胰腺癌的预后和免疫力
Haosheng Zheng1,2, Jian Tan1,2, Fei Qin1,2
1Department of Thoracic Surgery, Thoracic Cancer Center, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510655, Guangdong, China.
酸盐激酶M2 (PKM2) 在大多数癌症中被上调,与预后不佳相关,并影响瘤生长,免疫反应和化疗抵抗. 沉默PKM2通过调节自增强了对化疗的敏感性.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症新陈代谢 癌症新陈代谢
背景情况:
- 增强的葡萄糖分解是瘤代谢重编程的标志.
- 酸盐激酶M2 (PKM2) 是一个关键的酶,调节糖解速率.
- 之前的研究表明PKM2在特定癌症中的作用,但缺乏泛癌症分析.
研究的目的:
- 对Pyruvate Kinase M2 (PKM2) 表达,预后价值和功能作用进行全面的泛癌分析.
- 研究与PKM2.2相关的表观遗传调节,免疫微环境关联以及药物敏感性.
- 探索PKM2对化疗耐药性的影响,特别是食道状细胞癌.
主要方法:
- 使用多个公共数据库对PKM2表达和预后进行全癌症分析.
- 表观遗传学分析 (DNA促进物甲基化,m6A-甲基化基因相关性).
- 功能丰富,免疫细胞透,免疫检查点和药物敏感性分析.
- 通过基因沉默和自调节对PKM2在化学抵抗中的作用的实验验证.
主要成果:
- 在大多数分析的恶性瘤中,PKM2显著上调,与患者预后不佳有关.
- 在一些癌症中观察到PKM2 DNA促进物的低甲基化.
- PKM2表达与与m6A甲基化相关的基因具有正相关性,并且与免疫细胞透 (中性粒细胞,癌症相关纤维细胞) 有关.
- PKM2与免疫检查点 (CD274/PD-L1,CD276,HAVCR2) 和生长因子 (TGF-β1,VEGFA) 有着强烈的相关性.
- 沉默PKM2通过调节自而增加了食道状细胞癌中对思丁的敏感性.
结论:
- PKM2是一个重要的泛癌瘤基因,涉及瘤进展,免疫逃避和血管生成.
- PKM2的表观遗传调节和与免疫成分的关联突显了它在癌症中的多方面的作用.
- 向PKM2,特别是其在自介导化学抵抗中的作用,为克服治疗失败提供了一个有希望的治疗策略.
更多相关视频
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
08:30Immunophenotyping of Orthotopic Homograft Syngeneic of Murine Primary KPC Pancreatic Ductal Adenocarcinoma by Flow Cytometry
Published on: October 9, 2018
相关概念视频
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Tumor Immunotherapy
